Gil Blum from Needham maintained a Buy rating on Mereo Biopharma Group Plc (MREO – Research Report), with a price target of $5.00 Largest volume in company history.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.